Himalaya Nutravedics India H1 Profit Rises 33.3% to ₹4.4 Crore
Key highlights
- Himalaya Nutravedics India reported H1 FY27 revenue of ₹27.4 crore, up 35.6% year on year.
- H1 FY27 net profit was ₹4.4 crore, up 33.3% year on year.
- Operating margin improved to 19.3% from 16.3% in H1 FY26.
- The board appointed M/s Srinivasachary & Co. as internal auditor for FY 2026-27.
powered by IRIS

Himalaya Nutravedics India Ltd reported H1 FY27 net profit of ₹4.4 crore, up 33.3% year on year, on revenue from operations of ₹27.4 crore. The unaudited standalone results for the half year ended September 30, 2026 also showed an operating margin of 19.3%, compared with 16.3% in H1 FY26.
Know Himalaya Nutravedics India inside out
Results, valuation, peers and who's buying, in one view.
What did Himalaya Nutravedics India report for H1 FY27?
Himalaya Nutravedics India approved unaudited standalone financial results for H1 FY27 at its board meeting held on November 12, 2026. Revenue from operations was ₹27.4 crore, based on the disclosed figure of ₹2,741.43 lakh, while profit after tax was ₹4.4 crore, based on ₹444.11 lakh reported in the filing.
The company's reported revenue increased 35.6% from ₹20.2 crore in H1 FY26. Net profit rose 33.3% year on year from ₹3.3 crore. Profit before tax stood at ₹5.3 crore, compared with ₹3.3 crore in the corresponding half of the previous financial year. Total income was also ₹27.4 crore, matching revenue from operations in the results summary.
How did profitability and margins change during the period?
Himalaya Nutravedics India improved its operating margin to 19.3% in H1 FY27 from 16.3% in H1 FY26. The margin was also higher than 17.5% reported for H2 FY26, indicating improved profitability relative to both comparison periods disclosed in the results summary.
Profit before exceptional items and tax was ₹5.3 crore, against ₹3.5 crore in H1 FY26 and ₹4.0 crore in H2 FY26. The company reported no exceptional items in H1 FY27 or H2 FY26. H1 FY26 included an exceptional item of negative ₹0.2 crore, which meant profit before tax for that period was ₹3.3 crore.
What actions did the board take alongside the results?
Himalaya Nutravedics India appointed M/s Srinivasachary & Co., Chartered Accountants, as its internal auditor for FY 2026-27. The board also ratified the H1 FY27 standalone results, which were approved following the recommendation of the Audit Committee.
The board meeting was held on November 12, 2026, at the company's registered office. It commenced at 11:00 AM and concluded at 2:50 PM, according to the company disclosure. The financial results were accompanied by a limited review report from the auditor and were to be made available on the company's website.
The internal-auditor appointment is a governance-related disclosure separate from the operating performance reported for the half year. The filing identifies Srinivasachary & Co. as a chartered accountancy firm with firm registration number 0022815S. No further operational impact from the appointment was quantified in the disclosed material.
Got a follow-up? Ask IRIS
Why do the H1 results matter to investors?
Himalaya Nutravedics India's H1 FY27 figures show that revenue and net profit both grew by more than 30% year on year, while operating margin widened by 3 percentage points. For investors, the disclosed comparisons provide a clearer view of how the company's first-half performance changed against the same period last year and the immediately preceding half year.
The revenue increase of ₹7.2 crore from H1 FY26 to H1 FY27 was accompanied by a ₹1.1 crore increase in net profit on the rounded figures provided. Profit before tax rose by ₹2.0 crore over the same comparison. These changes are reflected in the company's standalone, unaudited results and should be assessed in that reporting context.
The filing also records that Himalaya Nutravedics India completed an initial public offering in September 2026 and listed on the BSE SME platform on September 29, 2026. It disclosed an allotment of 24.99 lakh equity shares at ₹106 each, aggregating ₹26.50 crore. This is relevant background because H1 FY27 covers the period in which the company entered the listed market.
How should the reported numbers be interpreted?
Himalaya Nutravedics India's results are standalone and unaudited for the half year ended September 30, 2026. The figures provide a six-month performance snapshot rather than a full-year outcome. Investors comparing these results with annual data should note that H1 FY27 and H2 FY26 are separate half-year periods.
The company reported a 12.8% sequential increase in net profit against H2 FY26 and a 35.6% year-on-year increase in revenue. Its operating margin rose from both comparison periods cited in the results summary. The release does not provide a segment-wise revenue split, product-wise demand data, or a forward financial forecast.
For market participants, the main disclosed operating indicators are revenue growth, profit growth and the margin movement. The appointment of an internal auditor adds a governance update, while the limited-review report and board approval establish the reporting process used for the half-year results.
Conclusion
Himalaya Nutravedics India reported higher revenue, net profit and operating margin in H1 FY27. Revenue reached ₹27.4 crore and net profit was ₹4.4 crore, while the 19.3% operating margin exceeded the levels reported in both H1 FY26 and H2 FY26. The board also approved the results and appointed an internal auditor for FY 2026-27.
The next items to watch are the company's subsequent financial disclosures, including whether revenue growth and the higher operating margin are maintained in the second half of FY27. Investors can also monitor disclosures related to the use of IPO proceeds and any operational information issued after the company's September 2026 BSE SME listing.


